AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2011
Oct 6, 2011
33488_dirs_2011-10-06_b8948db7-2013-427c-8128-062ae948d6b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (NONE)
CIK: 0001401667
Period of Report: 2011-10-04
Reporting Person: MUNJAL KAPIL (Former Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-04 | Common Stock, par value $0.0001 | D | 1000000 | $0.0133 | Disposed | 0 | Direct |
Footnotes
F1: On October 4, 2011, the Issuer repurchased from the Reporting Person an aggregate of 1,000,000 shares of common stock of the Issuer at a per share purchase price equal to $0.0133.
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8